Clinical Trial Update: PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial named PETREMAC is investigating personalized treatment for high-risk breast cancer. The trial is currently active but not recruiting an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Haukeland University Hospital | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING